Glaucoma is a leading cause of blindness, affecting over 60 million people worldwide. The disease is caused by damage to the optic nerve, which can lead to a loss of peripheral vision.
Traditionally, glaucoma has been diagnosed and monitored using visual field testing. However, this test can be difficult to perform and interpret, and it may not be sensitive enough to detect early signs of the disease.
A new technology called OPTOS Retinal exam is being developed to improve the detection and monitoring of glaucoma. This technology uses a combination of imaging and artificial intelligence to create detailed images of the retina and optic nerve.
The OPTOS Retinal exam is more sensitive than visual field testing, and it can be used to detect early signs of glaucoma in patients who would otherwise be missed. The technology is also easier to perform and interpret than visual field testing.
The OPTOS Retinal exam is still under development, but it has the potential to revolutionise the way glaucoma is diagnosed and monitored. This technology could help to save sight and improve the quality of life for millions of people around the world.